Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border
- PMID: 12223441
Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border
Abstract
Previous studies have shown that risk factors for oncogenic (high-risk) and nononcogenic (low-risk) human papillomavirus (HPV) infection differ. To determine the risk factors for oncogenic and nononcogenic HPV infection in women residing along the United States-Mexico border, a cross-sectional study of type-specific HPV prevalence was conducted. Women (N=2246) ages 15-79 years, living in communities on both sides of the United States-Mexico border and attending family planning clinics were recruited. Women were screened for HPV and cytology and were asked to complete a health questionnaire. HPV status was determined by PCR, and HPV genotyping was performed using a reverse line blot hybridization assay (Roche Molecular Systems, Inc., Alameda, CA). Logistic regression analysis was conducted to determine factors independently associated with oncogenic and nononcogenic HPV infection in separate analyses. Similar to previous studies, lifetime number of sexual partners was only associated with oncogenic HPV infection. In contrast, nononcogenic HPV infection appeared to be associated with recent sexual activity, suggesting that nononcogenic infections may be more transient. Results from this study add to the growing literature suggesting that transmission and persistence of HPV differs by oncogenicity.
Similar articles
-
Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1129-36. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11700260
-
A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.Cancer Epidemiol Biomarkers Prev. 2000 May;9(5):469-76. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10815691
-
Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):799-805. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9332762
-
The epidemiology of human papillomavirus infections.J Clin Virol. 2005 Mar;32 Suppl 1:S16-24. doi: 10.1016/j.jcv.2004.12.008. J Clin Virol. 2005. PMID: 15753008 Review.
-
[Physiopathology and epidemiology of HPV anogenital diseases].Ann Dermatol Venereol. 2000;127(10 Suppl):3S5-3S9. Ann Dermatol Venereol. 2000. PMID: 11116862 Review. French. No abstract available.
Cited by
-
Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis.Int J Public Health. 2019 Jul;64(6):943-955. doi: 10.1007/s00038-019-01261-w. Epub 2019 Jun 8. Int J Public Health. 2019. PMID: 31175391
-
Human papillomavirus infection and use of oral contraceptives.Br J Cancer. 2003 Jun 2;88(11):1713-20. doi: 10.1038/sj.bjc.6600971. Br J Cancer. 2003. PMID: 12771986 Free PMC article.
-
Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers.Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S163-9. doi: 10.1016/j.ygyno.2007.07.050. Epub 2007 Aug 29. Gynecol Oncol. 2007. PMID: 17727928 Free PMC article.